Literature DB >> 8639881

P2X1 receptor activation in HL60 cells.

G Buell1, A D Michel, C Lewis, G Collo, P P Humphrey, A Surprenant.   

Abstract

Recent cloning of the human P2X1 receptor revealed high levels of its messenger RNA in differentiated promyelocytes (HL60 cells). We found expression of P2X1 receptor protein in HL60 cells by radioligand binding, by immunohistochemistry, using a receptor specific antibody, and by electrophysiology. The currents elicited by adenosine triphosphate (ATP) had the expected properties of P2X1 receptors (rapid desensitization, mimicked by alpha,beta-methylene-ATP). However, these currents were only observed in cells that were pretreated with apyrase, which destroys extracellular ATP, or with suramin, a P2X receptor antagonist. This implies that HL60 cells release ATP, which chronically desensitizes the receptor. ATP release was detected by direct measurement, using the luciferin-luciferase assay. It is concluded that functional P2X1 receptors are present in the membrane of differentiated HL60 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639881

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Baculovirus expression provides direct evidence for heteromeric assembly of P2X2 and P2X3 receptors.

Authors:  K M Radford; C Virginio; A Surprenant; R A North; E Kawashima
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

2.  Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.

Authors:  J Simon; P Vigne; K M Eklund; A D Michel; A M Carruthers; P P Humphrey; C Frelin; E A Barnard
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Purification and Recognition of Recombinant Mouse P2X(1) Receptors Expressed in a Baculovirus System.

Authors:  Liping Chen; James P Hardwick; Peter McPhie; Michail V Sitkovsky; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  2000-10-16       Impact factor: 4.360

4.  Properties of P2X and P2Y receptors are dependent on artery diameter in the rat mesenteric bed.

Authors:  D P Gitterman; R J Evans
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

5.  Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors.

Authors:  B F King; M Liu; J Pintor; J Gualix; M T Miras-Portugal; G Burnstock
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors.

Authors:  Catherine Vial; Michael G Rolf; Martyn P Mahaut-Smith; Richard J Evans
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

7.  Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors.

Authors:  Dayane A Gomes; Zhilin Song; Wanida Stevens; Celia D Sladek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-22       Impact factor: 3.619

8.  P2 receptor-mediated signaling in mast cell biology.

Authors:  Elena Bulanova; Silvia Bulfone-Paus
Journal:  Purinergic Signal       Date:  2009-11-17       Impact factor: 3.765

9.  P2X2 and P2Y1 immunofluorescence in rat neostriatal medium-spiny projection neurones and cholinergic interneurones is not linked to respective purinergic receptor function.

Authors:  Peter Scheibler; Mihail Pesic; Heike Franke; Robert Reinhardt; Kerstin Wirkner; Peter Illes; Wolfgang Nörenberg
Journal:  Br J Pharmacol       Date:  2004-09       Impact factor: 8.739

10.  Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists.

Authors:  Yong-Chul Kim; Emidio Camaioni; Airat U Ziganshin; Xiao-Duo Ji; Brian F King; Scott S Wildman; Alexei Rychkov; Joshua Yoburn; Heaok Kim; Arvind Mohanram; T Kendall Harden; José L Boyer; Geoffrey Burnstock; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1998-10-01       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.